Literature DB >> 27729669

Biosimilars: What's in a Name?

Anne P Kim1.   

Abstract

Year:  2015        PMID： 27729669      PMCID： PMC5057188          DOI： 10.1310/hpj5010-847

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN： 0018-5787


× No keyword cloud information.
  3 in total

1.  Competition in the Age of Biosimilars.

Authors:  Amitabh Chandra; Jacqueline Vanderpuye-Orgle
Journal:  JAMA       Date:  2015-07-21       Impact factor: 56.272

2.  Assessment of pharmacists' views on biosimilar naming conventions.

Authors:  Sara Fernandez-Lopez; Denise Kazzaz; Mohamed Bashir; Trent McLaughlin
Journal:  J Manag Care Spec Pharm       Date:  2015-03

3.  Inflammatory diseases: Integrating biosimilars into clinical practice.

Authors:  Steven R Feldman
Journal:  Semin Arthritis Rheum       Date:  2015-04-09       Impact factor: 5.532
  3 in total
  1 in total

Review 1.  The Breakthrough of Biosimilars: A Twist in the Narrative of Biological Therapy.

Authors:  Eva Rahman Kabir; Shannon Sherwin Moreino; Mohammad Kawsar Sharif Siam
Journal:  Biomolecules       Date:  2019-08-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.